ACKR2 in hematopoietic precursors as a checkpoint of neutrophil release and anti-metastatic activity
The atypical chemokine receptor ACKR2 regulates immune responses. Here the authors confirm that ACKR2 depletion promotes primary tumor growth but show it has an anti-metastatic effect in mouse models of breast cancer by affecting myeloid differentiation and unleashing the anti-metastatic activity of...
Guardado en:
Autores principales: | Matteo Massara, Ornella Bonavita, Benedetta Savino, Nicoletta Caronni, Valeria Mollica Poeta, Marina Sironi, Elisa Setten, Camilla Recordati, Laura Crisafulli, Francesca Ficara, Alberto Mantovani, Massimo Locati, Raffaella Bonecchi |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Nature Portfolio
2018
|
Materias: | |
Acceso en línea: | https://doaj.org/article/3c65e1c5ccf540638c6d891c8d6bd90e |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
The atypical chemokine receptor ACKR3/CXCR7 is a broad-spectrum scavenger for opioid peptides
por: Max Meyrath, et al.
Publicado: (2020) -
Checkpoints
por: Jean Arasanayagam
Publicado: (2016) -
Glutamine metabolism regulates endothelial to hematopoietic transition and hematopoietic lineage specification
por: Leal Oburoglu, et al.
Publicado: (2021) -
Hematopoietic stem cell transplantation
por: Eleftheria Hatzimichael, et al.
Publicado: (2010) -
Lymphoid-biased hematopoietic stem cells and myeloid-biased hematopoietic progenitor cells have radioprotection activity
por: Shanshan Zhang, et al.
Publicado: (2021)